Search Results

Filter
  • 1-10 of  42,526 results for ""Factor VIIa""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Comparison of Low Dose Recombinant Factor VIIa and 4-Factor Prothrombin Complex Concentrate for Treatment of Bleeding Related to Cardiac Surgery.

Subjects: Factor VIIa*/Factor VIIa*/Factor VIIa*/administration & dosage ; Factor VIIa*/Factor VIIa*/Factor VIIa*/therapeutic use ; Factor VIIa*/Factor VIIa*/Factor VIIa*/adverse effects

  • Source: Journal of pharmacy practice [J Pharm Pract] 2024 Oct; Vol. 37 (5), pp. 1149-1156. Date of Electronic Publication: 2024 Jan 23.Publisher: Sage Publications Country of Publication: United States NLM ID: 8900945 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Good metabolic control is associated with decreased circulating factor VIIa- antithrombin complexes in type 2 diabetes: a cross-sectional study.

  • Authors : Gastoł J; Metabolic Diseases and Diabetology Clinical Department, University Hospital, Kraków, Poland.; Department of Metabolic Diseases, Jagiellonian University Medical College, Kraków, Poland.

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/blood ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/diagnosis ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/epidemiology

  • Source: Cardiovascular diabetology [Cardiovasc Diabetol] 2024 Nov 05; Vol. 23 (1), pp. 398. Date of Electronic Publication: 2024 Nov 05.Publisher: BioMed Central Country of Publication: England NLM ID: 101147637 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2840

Record details

×
Report

Cerebral infarction in a patient with inhibitor-positive hemophilia B treated with plasma-derived factor VIIa and factor X mixture.

  • Authors : Shimozawa K; Paediatrics, Nihon University Itabashi Hospital, 30-1 Oyaguchi kami-cho, Itabashi-ku, Tokyo, 173-8610, Japan.; Yagasaki H

Subjects: Cerebral Infarction*/Cerebral Infarction*/Cerebral Infarction*/etiology ; Cerebral Infarction*/Cerebral Infarction*/Cerebral Infarction*/blood ; Factor VIIa*/Factor VIIa*/Factor VIIa*/therapeutic use

  • Source: Annals of hematology [Ann Hematol] 2024 Jun; Vol. 103 (6), pp. 2161-2162. Date of Electronic Publication: 2024 Apr 13.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Current status and future prospects of activated recombinant coagulation factor VIIa, NovoSeven®, in the treatment of haemophilia and rare bleeding disorders.

  • Authors : Shima M; Thrombosis and Hemostasis Research Center, Nara Medical University, 840 Shijo‑cho, Kashihara City, Nara, 634-8522, Japan. .

Subjects: Factor VIIa*/Factor VIIa*/Factor VIIa*/therapeutic use ; Recombinant Proteins*/Recombinant Proteins*/Recombinant Proteins*/therapeutic use ; Hemophilia A*/Hemophilia A*/Hemophilia A*/drug therapy

  • Source: Annals of hematology [Ann Hematol] 2024 Aug; Vol. 103 (8), pp. 2647-2658. Date of Electronic Publication: 2023 Jun 30.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Nucleic acid sensing promotes inflammatory monocyte migration through biased coagulation factor VIIa signaling.

  • Authors : Zelaya H; Center for Thrombosis and Hemostasis, Johannes Gutenberg University Medical Center, Mainz, Germany.; National Scientific and Technical Research Council (CONICET), Tucuman, Argentina.

Subjects: Factor VIIa*/Factor VIIa*/Factor VIIa*/metabolism ; Monocytes*/Monocytes*/Monocytes*/metabolism; Animals

  • Source: Blood [Blood] 2024 Mar 07; Vol. 143 (10), pp. 845-857.Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020

Record details

×
Academic Journal

Changes in coagulation potential over time after administration of recombinant activated factor VII in an emicizumab-treated hemophilia A patient with inhibitors.

  • Authors : Osuna M; Department of Pediatrics, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8522, Japan.; Nakajima Y

Subjects: Hemophilia A*/Hemophilia A*/Hemophilia A*/drug therapy ; Hemophilia A*/Hemophilia A*/Hemophilia A*/blood ; Factor VIIa*/Factor VIIa*/Factor VIIa*/administration & dosage

  • Source: International journal of hematology [Int J Hematol] 2024 Nov; Vol. 120 (5), pp. 639-644. Date of Electronic Publication: 2024 Aug 07.Publisher: Springer Japan Country of Publication: Japan NLM ID: 9111627 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

The role of proteolytic cleavage at Arg 336 and Arg 372 of the A1 domain in factor VIIa/tissue factor-catalyzed reactions of B domain-deleted factor VIII.

  • Authors : Nakajima Y; Department of Pediatrics, Nara Medical University, Kashihara, Nara, Japan; Advanced Medical Science of Thrombosis and Hemostasis, Nara Medical University, Kashihara, Japan. Electronic address: .

Subjects: Factor VIIa* ; Thromboplastin*; Factor VIII/Factor VIII/Factor VIII/genetics

  • Source: Biochimica et biophysica acta. General subjects [Biochim Biophys Acta Gen Subj] 2024 Jan; Vol. 1868 (1), pp. 130501. Date of Electronic Publication: 2023 Nov 02.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101731726 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Exploring Hematoma Expansion Shift With Recombinant Factor VIIa: A Pooled Analysis of 4 Randomized Controlled Trials.

  • Authors : Yogendrakumar V; Department of Neurology, Royal Melbourne Hospital, University of Melbourne, Parkville, Victoria, Australia (V.Y.).; Mayer SA

Subjects: Factor VIIa*/Factor VIIa*/Factor VIIa*/therapeutic use ; Cerebral Hemorrhage*/Cerebral Hemorrhage*/Cerebral Hemorrhage*/drug therapy ; Cerebral Hemorrhage*/Cerebral Hemorrhage*/Cerebral Hemorrhage*/chemically induced

  • Source: Stroke [Stroke] 2023 Dec; Vol. 54 (12), pp. 2990-2998. Date of Electronic Publication: 2023 Oct 08.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0235266 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

The rare case of double valve surgery in a patient with factor VII deficiency.

  • Authors : Schoettler FI; Section of Cardiac Surgery, Department of Cardiac Sciences, Libin Cardiovascular Institute, University of Calgary, Canada.; Fatehi Hassanabad A

Subjects: Factor VII Deficiency*/Factor VII Deficiency*/Factor VII Deficiency*/complications ; Factor VIIa*/Factor VIIa*/Factor VIIa*/therapeutic use; Humans

  • Source: Perfusion [Perfusion] 2024 Nov; Vol. 39 (8), pp. 1748-1752. Date of Electronic Publication: 2023 Oct 31.Publisher: SAGE Publications Country of Publication: England NLM ID: 8700166 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Targeting tissue factor pathway inhibitor with concizumab to improve hemostasis in patients with Glanzmann thrombasthenia: an in vitro study.

  • Authors : Dubut J; Department of Haematology, University Hospital of Bordeaux, Pessac, France; Institut National de la Santé et de la Recherche Médicale U1034, Biology of Cardiovascular Disease, Pessac, France.

Subjects: Thrombasthenia*/Thrombasthenia*/Thrombasthenia*/blood ; Thrombasthenia*/Thrombasthenia*/Thrombasthenia*/drug therapy ; Hemostasis*/Hemostasis*/Hemostasis*/drug effects

  • Source: Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2024 Sep; Vol. 22 (9), pp. 2589-2600. Date of Electronic Publication: 2024 Jun 14.Publisher: Elsevier Country of Publication: England NLM ID: 101170508 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-7836

Record details

×
  • 1-10 of  42,526 results for ""Factor VIIa""